Preferred Label : Alport syndrome 1, X-linked;
Symbol : ATS1;
CISMeF acronym : ATS; ATS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Nephropathy and deafness, X-linked; ATS;
Description : Alport syndrome is an inherited disorder of the basement membrane, resulting in progressive
renal failure due to glomerulonephropathy, variable sensorineural hearing loss, and
variable ocular anomalies (review by Kashtan, 1999). Alport syndrome is a genetically
heterogeneous disorder, with all forms resulting from mutations in genes encoding
type IV collagen, which is a major structural component of the basement membrane.
Approximately 85% of cases of Alport syndrome are X-linked and about 15% are autosomal
recessive (203780); autosomal dominant inheritance (104200) is rare (Kashtan, 1999).
See also benign familial hematuria (BFH; 141200), a phenotypically similar, but milder
disorder. Alport syndrome is also a feature of 2 contiguous gene deletion syndromes
involving the COL4A5 gene: Alport syndrome and diffuse leiomyomatosis (308940) and
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME;
300194).;
Inheritance : X-linked dominant;
Molecular basis : Caused by mutation in the collagen, type IV, alpha-5 gene (COL4A5, 303630.0001);
Laboratory abnormalities : Hematuria, gross and microscopic; Proteinuria; Nephrotic syndrome;
Prefixed ID : #301050;
Origin ID : 301050;
UMLS CUI : C4746986;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT